Photo by nci from unsplash
Rivaroxaban (RIVA) is useful for stroke prevention in atrial fibrillation (AF) patients. Antiarrhythmic drugs (AADs) prevent the recurrence of AF in non-permanent AF (npAF). There are limited data regarding drug-drug… Click to show full abstract
Rivaroxaban (RIVA) is useful for stroke prevention in atrial fibrillation (AF) patients. Antiarrhythmic drugs (AADs) prevent the recurrence of AF in non-permanent AF (npAF). There are limited data regarding drug-drug interactions between RIVA and AADs. This study compares the bleeding and ischemic
Keywords:
atrial fibrillation;
non permanent;
combination antiarrhythmic;
rivaroxaban combination;
antiarrhythmic drugs
Journal Title: Journal of the American College of Cardiology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!